GlaxoSmithKline Plc Financials
| GSKN Stock | MXN 739.40 0.57 0.08% |
GlaxoSmithKline |
Understanding current and past GlaxoSmithKline Plc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GlaxoSmithKline Plc's financial statements are interrelated, with each one affecting the others. For example, an increase in GlaxoSmithKline Plc's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in GlaxoSmithKline Plc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GlaxoSmithKline plc. Check GlaxoSmithKline Plc's Beneish M Score to see the likelihood of GlaxoSmithKline Plc's management manipulating its earnings.
GlaxoSmithKline Plc Stock Summary
GlaxoSmithKline Plc competes with Bank of Nova Scotia, Verizon Communications, Prudential Financial, GMxico Transportes, and FIBRA Storage. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GLAXOSMITHKLINE is traded on Mexico Stock Exchange in Mexico.| Instrument | Mexico Stock View All |
| Exchange | Mexican Exchange |
| ISIN | US37733W2044 |
| Business Address | 980 Great West |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.gsk.com |
| Phone | 44 20 8047 5000 |
| Currency | MXN - Mexican Peso |
You should never invest in GlaxoSmithKline Plc without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of GlaxoSmithKline Stock, because this is throwing your money away. Analyzing the key information contained in GlaxoSmithKline Plc's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
GlaxoSmithKline Plc Key Financial Ratios
GlaxoSmithKline Plc's financial ratios allow both analysts and investors to convert raw data from GlaxoSmithKline Plc's financial statements into concise, actionable information that can be used to evaluate the performance of GlaxoSmithKline Plc over time and compare it to other companies across industries.| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 | |||
| Number Of Employees | 45 | |||
| Beta | 0.28 | |||
| Z Score | 41.4 |
GlaxoSmithKline Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GlaxoSmithKline Plc's current stock value. Our valuation model uses many indicators to compare GlaxoSmithKline Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GlaxoSmithKline Plc competition to find correlations between indicators driving GlaxoSmithKline Plc's intrinsic value. More Info.GlaxoSmithKline plc is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GlaxoSmithKline plc is roughly 4.75 . Comparative valuation analysis is a catch-all model that can be used if you cannot value GlaxoSmithKline Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GlaxoSmithKline Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.GlaxoSmithKline plc Systematic Risk
GlaxoSmithKline Plc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GlaxoSmithKline Plc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on GlaxoSmithKline plc correlated with the market. If Beta is less than 0 GlaxoSmithKline Plc generally moves in the opposite direction as compared to the market. If GlaxoSmithKline Plc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GlaxoSmithKline plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GlaxoSmithKline Plc is generally in the same direction as the market. If Beta > 1 GlaxoSmithKline Plc moves generally in the same direction as, but more than the movement of the benchmark.
GlaxoSmithKline Plc December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GlaxoSmithKline Plc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GlaxoSmithKline plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of GlaxoSmithKline plc based on widely used predictive technical indicators. In general, we focus on analyzing GlaxoSmithKline Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GlaxoSmithKline Plc's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 14.39 | |||
| Value At Risk | (0.08) | |||
| Potential Upside | 0.1504 |
Additional Tools for GlaxoSmithKline Stock Analysis
When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.